|

XTR004 Clinical Trials

1 actively recruiting trial

Also known as: Drug: 99mTechnicium Sestamibi, Procedure: Coronary angiography

Pipeline

Phase 3: 1

Top Sponsors

  • Sinotau Pharmaceutical Group1

Indications

  • Coronary Artery Disease (CAD)1
  • Heart Disease1

Other1 trial

Comparison of Diagnostic Accuracy Between XTR004 PET MPI and the Composite Index of Quantitative Coronary Angiography (QCA) and Fractional Flow Reserve (FFR)
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.